Floatz logo

CEFOXITIN

Antibiotic Prophylaxis

Central Hospital, Nancy, FranceSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Antibiotic Prophylaxis cohort.

Asset / SponsorPhaseRating
Ceftriaxone
Nadeem Iqbal
Phase 3B
Cefazolin
Fabiola Soares Moreira Campos
N/AD

Same molecule, other indications

CEFOXITIN is also rated in:

pancreas disorderDormant
B
Indicative ·
62 / 100
View asset →
malignant pancreatic neoplasmDormant
B
Indicative ·
57 / 100
View asset →
pulmonary non-tuberculous mycobacterial infectionDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →